AI assistant
IONIS PHARMACEUTICALS INC — Director's Dealing 2011
Jan 3, 2011
30591_dirs_2011-01-03_79526682-e64f-44bd-832c-c74aff334aad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2011-01-01
Reporting Person: BENNETT C FRANK (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-01-01 | Common Stock | J | 493 | $7.7945 | Acquired | 1054 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-01-03 | Employee Stock Option (right to buy) | $10.29 | A | 27250 | Acquired | 2018-01-02 | Common Stock (27250) | Direct |
Footnotes
F1: Reporting 493 shares acquired under the Isis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on January 1, 2011.
F2: Grant of 1-3-11 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option will vest and become exercisable on 1-3-12. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 6,813 shares per year. The option is exercisable as to 0 shares on 1-3-11.